Author:
van Heerebeek Loek,Franssen Constantijn P. M.,Hamdani Nazha,Verheugt Freek W. A.,Somsen G. Aernout,Paulus Walter J.
Publisher
Springer Science and Business Media LLC
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine,Emergency Medicine
Reference100 articles.
1. Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355:251–9.
2. The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). Eur Heart J 2011, Aug 6, epub ahead of print.
3. Paulus WJ, van Ballegoij JJ. Treatment of heart failure with normal ejection fraction: an inconvenient truth! J Am Coll Cardiol. 2010;55:526–37.
4. • Schwartzenberg S, Redfield MM, From AM, et al. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy. J Am Coll Cardiol. 2012;59:442–51. This article provides evidence that HFpEF and HFrEF represent distinct heart failure phenotypes as hemodynamic responses to acute vasodilator therapy substantially differ between HFpEF and HFrEF patients.
5. van Heerebeek L, Borbely A, Niessen HWM, et al. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation. 2006;113:1966–73.
Cited by
96 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献